Vacuum mattress positioning reduces temperature variability during superficial hyperthermia for recurrent breast cancer

Vacuum mattress positioning reduced between-session mean-temperature variability from 0.65°C to 0.40°C during superficial hyperthermia in 24 patients.

KEY POINTS

  • The retrospective CENTIMETRE study evaluated 24 patients with locoregionally recurrent breast cancer undergoing superficial hyperthermia (SHT) during chest-wall reirradiation at Erasmus MC Cancer Institute. Twelve patients were positioned using conventional soft cushions and 12 using vacuum mattresses. Treatment consisted of approximately 60-minute weekly hyperthermia sessions, typically over five fractions, delivered using multiple 434-MHz Lucite cone applicators.
  • Vacuum mattress positioning significantly reduced the primary endpoint of interfractional temperature variability. The median patient-level range of steady-state mean temperature across sessions decreased from 0.65°C with soft cushions to 0.40°C with vacuum mattresses (p<0.001). The Hodges–Lehmann estimate of the between-group difference was −0.30°C (95% CI −0.40 to −0.15°C), indicating more reproducible temperature measurements across treatment fractions.
  • Other measures of temperature variability showed similar improvements. Median interfractional variability in maximum temperature decreased from 1.05°C to 0.50°C (p<0.001), while minimum-temperature variability decreased from 0.90°C to 0.40°C (p<0.001). Variability in the within-fraction temperature range also decreased from 1.20°C to 0.70°C (p<0.001). These findings suggest greater thermal stability with immobilization, although the measurements primarily represented superficial rather than intratumoral temperature.
  • Temperature improvements were not explained by a significant difference in applied power. Median interfractional variability of net power was 39.5 W with soft cushions versus 32.0 W with vacuum mattresses (p=0.319). In models of temperature rise versus applied power, vacuum positioning demonstrated a stronger positive association (β≈0.0109; p<0.000001) than conventional positioning (β≈0.0046; p≈0.054). After accounting for waterbolus temperature, mean superficial temperature was approximately 0.06°C higher with four applicators and 0.37°C higher with six applicators in the vacuum group.
  • Vacuum positioning did not significantly alter the observed rate of hyperthermia-related adverse events. Among 119 delivered fractions, grade 2 events occurred in 0/60 soft-cushion fractions versus 2/59 vacuum fractions (3.4%), while grade 3 events occurred in 3/60 (5.0%) versus 1/59 (1.7%). No grade 4 events or treatment discontinuations occurred. Mixed-effects analysis found no significant association between vacuum use and grade ≥2 toxicity (OR 1.02, 95% CI 0.24–4.38; p=0.976).
  • The study evaluated temperature reproducibility rather than therapeutic effectiveness. After exclusion of protocol deviations and temperature outliers, 60 soft-cushion and 54 vacuum fractions contributed to the principal temperature analyses. The small sample, retrospective implementation, changing staff experience, variable applicator positioning, and unmeasured tissue perfusion could influence the observed differences. Tumor response, thermal dose within the target, and long-term locoregional control were not evaluated.

CLINICAL TAKEAWAY

Vacuum mattress immobilization was associated with more reproducible superficial temperatures during hyperthermia for recurrent breast cancer, without a detectable increase in treatment-related adverse events. This relatively simple positioning intervention may improve consistency of thermal delivery, particularly for extensive chest-wall targets requiring multiple applicators. However, the study is small and retrospective, and improved temperature stability has not been shown to translate into better tumor control.

SOURCE

Technical Innovations & Patient Support in Radiation Oncology

Browse more research Suggest a correction